BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:astegolimab readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of astegolimab\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05878769-1435@assetmemo.bio
DTSTAMP:20261121T005624Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:astegolimab: Phase 3 readout est. (NCT05878769)
DESCRIPTION:astegolimab\, phase 3\, Chronic Obstructive Pulmonary Disease.\
 nStudy: A Study to Evaluate the Long-Term Safety of Astegolimab in Partici
 pants With Chronic Obstructive Pulmonary Disease (COPD)\nEstimated primary
  completion: 30 June 2027. This is a ClinicalTrials.gov estimate\, not a c
 onfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio
 /drug/astegolimab#upcoming-events\nRegistry record: https://clinicaltrials
 .gov/study/NCT05878769
URL:https://assetmemo.bio/drug/astegolimab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
